Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Gel for Painful Diabetic Neuropathy
NCT02068027Phase 2Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic neuropathy comparing Clonidine Gel 0.1% with Placebo (2 arms). Primary endpoint: Change From Baseline to Day 84 in Numeric Pain Rating Scale Score. Started Mar 2014; status: completed.
02
Drugs
clonidine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT02068027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068027.